Preventable Vaccines global industry size is estimated to be worth US$XX million in 2022 and is forecast to a readjusted size of US$XX million by 2028 with a CAGR of XX% during the forecast period 2022-2028. Fully considering the economic change by this health crisis (Covid), Adult Preventable Vaccines accounting for XX% of the Preventable Vaccines global market in 2021, is projected to value US$XX million by 2028, growing at a revised XX% CAGR from 2023 to 2028. While Bacterial Diseases segment is altered to an XX% CAGR throughout this forecast period.
The global key companies of Preventable Vaccines include GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche, AstraZeneca, Mitsubishi Tanabe Pharma, Lupin, Serum Institute of India, LG Life Sciences, S K Chemicals, Shenzhen Kangtai Biological Products, Sinovac Biotech, Janssen Pharmaceuticals, Crucell, Bavarian Nordic, Baxter, Bharat Biotech, Dynavax, Bausch Health, Protein Sciences, Panacea Biotec, etc. In 2022, the global top five players have a share approximately XX% in terms of revenue.
In terms of Production Side,
This report researches the Preventable Vaccines capacity, production, growth rate, market share by manufacturers and by region (region level and country level), from 2017 to 2022, and forecast to 2028.
In terms of Sales Side,
This report focuses on the sales of Preventable Vaccines by region (region level and country level), by company, by Type and by Application. from 2017 to 2022 and forecast to 2028.
This research report explores the key market segments: Type and Application. The report offers an in-depth breakdown of type and application segments, and their sub-segments. The growth potential of each segment have been examined by industry experts in this report. This section of the report also provides sales and revenue forecast data by type and application segments, based on sales, price, and revenue for the period 2017-2028. Additionally, the report features a value chain and raw material analysis of the key segments.
Segment by Type
Adult Preventable Vaccines
Pediatric Preventable Vaccines
Segment by Application
Bacterial Diseases
Virus Diseases
The report includes a section on key growth opportunities, which will help the key players to simplify complex issues and frame future strategies to compete in this competitive environment. This section will assist the players to boldly position their business.
Competitive Outlook
This section of the report provides an in-depth analysis of the competitive landscape of the market. The report profiles the key players in the market. It also provides reliable sales and revenue data of the players for the period 2017-2022. With the help of this report, key players, stakeholders, and other participants will be able to stay up-to-date with the recent and upcoming developments in the market, further aiding them in making efficient choices. The prime players profiled in this report are:
Companies
GlaxoSmithKline
Merck
Novartis
Pfizer
Sanofi
Takeda Pharmaceutical
Abbott
Roche
AstraZeneca
Mitsubishi Tanabe Pharma
Lupin
Serum Institute of India
LG Life Sciences
S K Chemicals
Shenzhen Kangtai Biological Products
Sinovac Biotech
Janssen Pharmaceuticals
Crucell
Bavarian Nordic
Baxter
Bharat Biotech
Dynavax
Bausch Health
Protein Sciences
Panacea Biotec
Note: We can also add companies which are not part of the above list
Global Preventable Vaccines market: regional analysis, the major regions covered in the report are:
North America (U.S., Canada, Mexico)
Europe (Germany, U.K., France, Italy, Russia, Spain etc.)
Asia-Pacific (China, India, Japan, Southeast Asia etc.)
South America (Brazil, Argentina etc.)
Middle East & Africa (Saudi Arabia, South Africa etc.)
Q: Who are the key players in the Preventable Vaccines market
A: The key players in the market are GlaxoSmithKline, Merck, Novartis, Pfizer, Sanofi, Takeda Pharmaceutical, Abbott, Roche, AstraZeneca, Mitsubishi Tanabe Pharma, Lupin, Serum Institute of India, LG Life Sciences, S K Chemicals, Shenzhen Kangtai Biological Products, Sinovac Biotech, Janssen Pharmaceuticals, Crucell, Bavarian Nordic, Baxter, Bharat Biotech, Dynavax, Bausch Health, Protein Sciences, Panacea Biotec.
Q: What is the revenue and sales data of the key players of Preventable Vaccines industry
A: The revenue and sales data of the key players of Preventable Vaccines industry is mentioned in full report.
Q: What are the recent and upcoming developments in the Preventable Vaccines market
A: The recent and upcoming developments in the Preventable Vaccines market are mentioned in this report.
Q: What are the main objectives of the Preventable Vaccines industry report
A: The main objectives of Preventable Vaccines industry report are to provide reliable sales and revenue data of the key players and to provide a comprehensive analysis of the competitive landscape.
Q: What are the key highlights of the Preventable Vaccines market research report
A: The key highlights of Preventable Vaccines industry report are to help players in decision making, the revenue and sales data of other players, and the recent and upcoming developments in the market.
Q: What is the scope of the Preventable Vaccines report
A: The Preventable Vaccines market report covers the market for the period 2017-2028.
Q: What is the methodology of the Preventable Vaccines report
A: The methodology of Preventable Vaccines industry report is based on primary and secondary sources.
Table of Contents
Part 1 Market Overview
1.1 Market Definition
1.2 Market Development
1.2.1 Current Situation
1.2.2 Aspects of COVID-19 Impact
1.3 By Type
Table Type of Preventable Vaccines
Figure Global Preventable Vaccines Market Share by Type in 2021
1.4 By Application
Table Application of Preventable Vaccines
Figure Global Preventable Vaccines Market Share by Application in 2021
1.5 By Region
Figure Global Preventable Vaccines Market Share by Region in 2021
Figure Asia Preventable Vaccines Market Share by Region in 2021
Part 2 Key Companies
2.1 GlaxoSmithKline
2.1.1 Company Profile
Table GlaxoSmithKline Overview List
2.1.2 Products & Services Overview
2.1.3 Sales Data List
Table Preventable Vaccines Business Operation of GlaxoSmithKline (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
2.2 Merck
2.3 Novartis
2.4 Pfizer
2.5 Sanofi
2.6 Takeda Pharmaceutical
2.7 Abbott
2.8 Roche
2.9 AstraZeneca
2.10 Mitsubishi Tanabe Pharma
2.11 Lupin
2.12 Serum Institute of India
2.13 LG Life Sciences
2.14 S K Chemicals
2.15 Shenzhen Kangtai Biological Products
2.16 Sinovac Biotech
2.17 Janssen Pharmaceuticals
2.18 Crucell
2.19 Bavarian Nordic
2.20 Baxter
2.21 Bharat Biotech
2.22 Dynavax
2.23 Bausch Health
2.24 Protein Sciences
2.25 Panacea Biotec
Part 3 Global Market Status and Future Forecast
3.1 Global Market by Region
Table Global Preventable Vaccines Market by Region, 2017-2021 (Million USD)
Figure Global Preventable Vaccines Market Share by Region in 2021 (Million USD)
Table Global Preventable Vaccines Market by Region, 2017-2021 (Volume)
Figure Global Preventable Vaccines Market Share by Region in 2021 (Volume)
Table Price List by Region, 2017-2021
3.2 Global Market by Company
Table Global Preventable Vaccines Market by Company, 2017-2021 (Million USD)
Figure Global Preventable Vaccines Market Share by Company in 2021 (Million USD)
Table Global Preventable Vaccines Market by Company, 2017-2021 (Volume)
Figure Global Preventable Vaccines Market Share by Company in 2021 (Volume)
Table Price List by Company, 2017-2021
3.3 Global Market by Type
Table Global Preventable Vaccines Market by Type, 2017-2021 (Million USD)
Figure Global Preventable Vaccines Market Share by Type in 2021 (Million USD)
Table Global Preventable Vaccines Market by Type, 2017-2021 (Volume)
Figure Global Preventable Vaccines Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
3.4 Global Market by Application
Table Global Preventable Vaccines Market by Application, 2017-2021 (Million USD)
Figure Global Preventable Vaccines Market Share by Application in 2021 (Million USD)
Table Global Preventable Vaccines Market by Application, 2017-2021 (Volume)
Figure Global Preventable Vaccines Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
3.5 Global Market by Forecast
Figure Global Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Global Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
Part 4 Asia-Pacific Market Status and Future Forecast
4.1 Asia-Pacific Market by Type
Table Asia-Pacific Preventable Vaccines Market by Type, 2017-2021 (Million USD)
Figure Asia-Pacific Preventable Vaccines Market Share by Type in 2021 (Million USD)
Table Asia-Pacific Preventable Vaccines Market by Type, 2017-2021 (Volume)
Figure Asia-Pacific Preventable Vaccines Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
4.2 Asia-Pacific Market by Application
Table Asia-Pacific Preventable Vaccines Market by Application, 2017-2021 (Million USD)
Figure Asia-Pacific Preventable Vaccines Market Share by Application in 2021 (Million USD)
Table Asia-Pacific Preventable Vaccines Market by Application, 2017-2021 (Volume)
Figure Asia-Pacific Preventable Vaccines Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
4.3 Asia-Pacific Market by Geography
4.3.1 China Market Status and Future Forecast
Figure China Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure China Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure China Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure China Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
4.3.2 Southeast Asia Market Status and Future Forecast
Figure Southeast Asia Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Southeast Asia Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Southeast Asia Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Southeast Asia Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
4.3.3 India Market Status and Future Forecast
Figure India Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure India Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure India Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure India Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
4.3.4 Japan Market Status and Future Forecast
Figure Japan Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Japan Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Japan Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Japan Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
4.3.5 Korea Market Status and Future Forecast
Figure Korea Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Korea Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Korea Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Korea Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
4.3.6 Oceania Market Status and Future Forecast
Figure Oceania Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Oceania Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Oceania Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Oceania Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
4.4 Asia-Pacific Market by Forecast
Figure Asia-Pacific Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Asia-Pacific Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
Part 5 Europe Market Status and Future Forecast
5.1 Europe Market by Type
Table Europe Preventable Vaccines Market by Type, 2017-2021 (Million USD)
Figure Europe Preventable Vaccines Market Share by Type in 2021 (Million USD)
Table Europe Preventable Vaccines Market by Type, 2017-2021 (Volume)
Figure Europe Preventable Vaccines Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
5.2 Europe Market by Application
Table Europe Preventable Vaccines Market by Application, 2017-2021 (Million USD)
Figure Europe Preventable Vaccines Market Share by Application in 2021 (Million USD)
Table Europe Preventable Vaccines Market by Application, 2017-2021 (Volume)
Figure Europe Preventable Vaccines Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
5.3 Europe Market by Geography
5.3.1 Germany Market Status and Future Forecast
Figure Germany Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Germany Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Germany Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Germany Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.3.2 UK Market Status and Future Forecast
Figure UK Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure UK Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure UK Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure UK Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.3.3 France Market Status and Future Forecast
Figure France Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure France Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure France Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure France Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.3.4 Italy Market Status and Future Forecast
Figure Italy Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Italy Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Italy Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Italy Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.3.5 Russia Market Status and Future Forecast
Figure Russia Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Russia Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Russia Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Russia Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.3.6 Spain Market Status and Future Forecast
Figure Spain Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Spain Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Spain Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Spain Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.3.6 Netherlands Market Status and Future Forecast
Figure Netherlands Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Netherlands Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Netherlands Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Netherlands Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.3.7 Turkey Market Status and Future Forecast
Figure Turkey Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Turkey Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Turkey Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Turkey Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.3.6 Switzerland Market Status and Future Forecast
Figure Switzerland Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Switzerland Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Switzerland Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Switzerland Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
5.4 Europe Market by Forecast
Figure Europe Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Europe Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
Part 6 North America Market Status and Future Forecast
6.1 North America Market by Type
Table North America Preventable Vaccines Market by Type, 2017-2021 (Million USD)
Figure North America Preventable Vaccines Market Share by Type in 2021 (Million USD)
Table North America Preventable Vaccines Market by Type, 2017-2021 (Volume)
Figure North America Preventable Vaccines Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
6.2 North America Market by Application
Table North America Preventable Vaccines Market by Application, 2017-2021 (Million USD)
Figure North America Preventable Vaccines Market Share by Application in 2021 (Million USD)
Table North America Preventable Vaccines Market by Application, 2017-2021 (Volume)
Figure North America Preventable Vaccines Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
6.3 North America Market by Geography
6.3.1 United States Market Status and Future Forecast
Figure United States Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure United States Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure United States Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure United States Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
6.3.2 Canada Market Status and Future Forecast
Figure Canada Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Canada Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Canada Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Canada Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
6.3.3 Mexico Market Status and Future Forecast
Figure Mexico Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Mexico Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Mexico Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Mexico Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
6.4 North America Market by Forecast
Figure North America Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure North America Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
Part 7 South America Market Status and Future Forecast
7.1 South America Market by Type
Table South America Preventable Vaccines Market by Type, 2017-2021 (Million USD)
Figure South America Preventable Vaccines Market Share by Type in 2021 (Million USD)
Table South America Preventable Vaccines Market by Type, 2017-2021 (Volume)
Figure South America Preventable Vaccines Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
7.2 South America Market by Application
Table South America Preventable Vaccines Market by Application, 2017-2021 (Million USD)
Figure South America Preventable Vaccines Market Share by Application in 2021 (Million USD)
Table South America Preventable Vaccines Market by Application, 2017-2021 (Volume)
Figure South America Preventable Vaccines Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
7.3 South America Market by Geography
7.3.1 Brazil Market Status and Future Forecast
Figure Brazil Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Brazil Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Brazil Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Brazil Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
7.3.2 Argentina Market Status and Future Forecast
Figure Argentina Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Argentina Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Argentina Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Argentina Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
7.3.3 Columbia Market Status and Future Forecast
Figure Columbia Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Columbia Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Columbia Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Columbia Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
7.3.4 Chile Market Status and Future Forecast
Figure Chile Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Chile Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Chile Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Chile Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
7.3.5 Peru Market Status and Future Forecast
Figure Peru Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure Peru Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure Peru Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Peru Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
7.4 South America Market by Forecast
Figure South America Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure South America Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
Part 8 Middle East & Africa Market Status and Future Forecast
8.1 Middle East & Africa Market by Type
Table Middle East & Africa Preventable Vaccines Market by Type, 2017-2021 (Million USD)
Figure Middle East & Africa Preventable Vaccines Market Share by Type in 2021 (Million USD)
Table Middle East & Africa Preventable Vaccines Market by Type, 2017-2021 (Volume)
Figure Middle East & Africa Preventable Vaccines Market Share by Type in 2021 (Volume)
Table Price List by Type, 2017-2021
8.2 Middle East & Africa Market by Application
Table Middle East & Africa Preventable Vaccines Market by Application, 2017-2021 (Million USD)
Figure Middle East & Africa Preventable Vaccines Market Share by Application in 2021 (Million USD)
Table Middle East & Africa Preventable Vaccines Market by Application, 2017-2021 (Volume)
Figure Middle East & Africa Preventable Vaccines Market Share by Application in 2021 (Volume)
Table Price List by Application, 2017-2021
8.3 Middle East & Africa Market by Geography
8.3.1 GCC Market Status and Future Forecast
Figure GCC Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure GCC Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure GCC Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure GCC Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
8.3.2 North Africa Market Status and Future Forecast
Figure North Africa Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure North Africa Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure North Africa Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure North Africa Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
8.3.3 South Africa Market Status and Future Forecast
Figure South Africa Preventable Vaccines Market Market Status, 2017-2021 (Million USD)
Figure South Africa Preventable Vaccines Market Market Status, 2017-2021 (Volume)
Figure South Africa Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure South Africa Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
8.4 Middle East & Africa Market by Forecast
Figure Middle East & Africa Preventable Vaccines Market Forecast, 2022E-2028F (Million USD)
Figure Middle East & Africa Preventable Vaccines Market Forecast, 2022E-2028F (Volume)
Part 9 Market Features
9.1 Product Features
9.2 Price Features
9.3 Channel Features
9.4 Purchasing Features
Part 10 Investment Opportunity
10.1 Regional Investment Opportunity
10.2 Industry Investment Opportunity
PART 11 Coronavirus Impact
11.1 Impact on Industry Upstream
11.2 Impact on Industry Downstream
11.3 Impact on Industry Channels
11.4 Impact on Industry Competition
11.5 Impact on Industry Obtain Employment
Part 12 Conclusion